BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27423604)

  • 21. [A Case of IgG4-related Hypertrophic Pachymeningitis].
    Hayashi K; Somagawa C; Hayashi Y; Iwanaga M
    No Shinkei Geka; 2018 Dec; 46(12):1103-1109. PubMed ID: 30572308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertrophic Pachymeningitis Demonstrated by Whole-Body 67Ga Scintigraphy.
    Ishii S; Sugawara S; Yamakuni R; Sekino H; Ito H
    Clin Nucl Med; 2022 Feb; 47(2):e149-e151. PubMed ID: 34284475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical image and pathology of hypertrophic cranial pachymeningitis.
    Shi CH; Niu ST; Zhang ZQ
    Genet Mol Res; 2014 Dec; 13(4):10501-9. PubMed ID: 25511033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of idiopathic hypertrophic cranial pachymeningitis manifested only by positive rheumatoid factor and abnormal findings of the anterior falx.
    Kanemoto M; Ota Y; Karahashi T; Nozue N
    Rheumatol Int; 2005 Apr; 25(3):230-3. PubMed ID: 15660236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A selected case series of idiopathic hypertrophic pachymeningitis in a single center: Pathological characteristics and case-oriented review.
    Yu H; Lu C; Duan W; Dong Y; Wang Z; Wang X; Jian F
    J Neuroimmunol; 2023 Oct; 383():578191. PubMed ID: 37660537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapidly progressive fatal idiopathic hypertrophic pachymeningitis with brainstem involvement in a child.
    Tsuchida K; Fukumura S; Yamamoto A; Akiyama Y; Hirano H; Tsutsumi H
    Childs Nerv Syst; 2018 Sep; 34(9):1795-1798. PubMed ID: 29730790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-GFAP Antibody-Associated Hypertrophic Pachymeningitis.
    Tan C; Zhong M; Yao Z; Hong S; Jiang L; Jiang Y
    Neuropediatrics; 2022 Apr; 53(2):143-145. PubMed ID: 35148545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature.
    Peng A; Yang X; Wu W; Xiao Z; Xie D; Ge S
    Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):2915-2923. PubMed ID: 30328500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nationwide survey of hypertrophic pachymeningitis in Japan.
    Yonekawa T; Murai H; Utsuki S; Matsushita T; Masaki K; Isobe N; Yamasaki R; Yoshida M; Kusunoki S; Sakata K; Fujii K; Kira J
    J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):732-9. PubMed ID: 24273222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertrophic cervical spine pachymeningitis due to sarcoidosis: a case report.
    Yacoub HA; Li PM; Bemporad JA; Khaitov D; Brown DF
    Hosp Pract (1995); 2019 Apr; 47(2):99-103. PubMed ID: 30682899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic hypertrophic cranial pachymeningitis: clinicoradiological spectrum and therapeutic options.
    Hatano N; Behari S; Nagatani T; Kimura M; Ooka K; Saito K; Yoshida J
    Neurosurgery; 1999 Dec; 45(6):1336-42; discussion 1342-4. PubMed ID: 10598701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical approach to hypertrophic pachymeningitis.
    Abrantes FF; Moraes MPM; Rezende Filho FM; Pedroso JL; Barsottini OGP
    Arq Neuropsiquiatr; 2020 Dec; 78(12):797-804. PubMed ID: 33295420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging characteristics of hypertrophic pachymeningitis due to ANCA-associated vasculitis.
    Takagi T; Okada M; Nakamura M; Hanari T; Nakata T; Teraoka M; Hato N
    Auris Nasus Larynx; 2022 Oct; 49(5):875-879. PubMed ID: 35074241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertrophic pachymeningitis and ophthalmological disturbances: description of two case reports].
    Pareja-Esteban J; Gutiérrez-Solana S; Cedazo M; Sánchez-Cordón B; Gamo-Gallego M; Teus MA
    Arch Soc Esp Oftalmol; 2008 Aug; 83(8):497-500. PubMed ID: 18661447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mantle cell lymphoma manifesting neurological symptoms similar to those of hypertrophic cranial pachymeningitis.
    Ishiyama K; Okada M; Anzai N; Tashima M
    Rinsho Ketsueki; 2011 Nov; 52(11):1788-93. PubMed ID: 22185803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Headache profile in patients with idiopathic hypertrophic cranial pachymeningitis.
    Wang YJ; Fuh JL; Lirng JF; Lu SR; Wang SJ
    Headache; 2004 Oct; 44(9):916-23. PubMed ID: 15447702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Idiopathic hypertrophic cranial pachymeningitis].
    Beier D; Wilhelm H
    Klin Monbl Augenheilkd; 2005 Sep; 222(9):740-5. PubMed ID: 16175486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cranial pachymeningitis of unknown origin: a study of seven cases.
    Masson C; Hénin D; Hauw JJ; Rey A; Raverdy P; Masson M
    Neurology; 1993 Jul; 43(7):1329-34. PubMed ID: 8327133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLE pachymeningitis and multiple cranial nerve palsies: a case report and review of the literature.
    John TJ; John K; du Plessis L; Manie M
    Lupus; 2019 Aug; 28(9):1154-1157. PubMed ID: 31333063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertrophic pachymeningitis: case report.
    de Deus-Silva L; Queiroz Lde S; Zanardi Vd Vde A; Ghizoni E; Pereira Hda C; Malveira GL; Pirani C; Damasceno BP; Cendes F
    Arq Neuropsiquiatr; 2003 Mar; 61(1):107-11. PubMed ID: 12715031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.